Abvance Therapeutics, Inc.

Date of Award

06.18.2024

Program

Improve Outcomes

Amount

$4,738,993.00

Term of Grant

26 months

Project Title

Development of ABV100, a fixed-ratio coformulation of insulin and glucagon